透导管与双主动脉患者的手术置换相比:更新的元分析
Peter S Giannaris1, Viren S Sehgal1, Branden Tejada1
1Medical Student.
The British journal of cardiology
|September 26, 2024
概括
透气管大动脉置换 (TAVR) 显示出较低的出血风险,但需要更高的起器,而非双大动脉患者的手术大动脉置换 (SAVR). 为了获得长期的结果,需要更多的研究.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
背景情况:
- 双主动脉 (BAV) 容易使患者患上主动脉狭窄症.
- 过导管大动脉置换 (TAVR) 和手术大动脉置换 (SAVR) 是主要的治疗选择.
- 对BAV患者的比较疗效数据至关重要.
研究的目的:
- 为了比较TAVR与SAVR在BAV患者的疗效.
- 分析短期结果,包括死亡率,中风,出血和并发症.
主要方法:
- 对比研究的双对元分析.
- 纳入标准:对TAVR与SAVR在BAV患者中的比较研究.
- 排除标准:单臂研究,动物研究,三形态学.
- 使用随机效应模型组合的结果.
主要成果:
- 包括60,858名患者 (包括7,565名TAVR和53,293名SAVR).
- TAVR显示30天主要出血风险显著降低 (RR0.29,p=0.01).
- TAVR显示永久心脏起器安置的风险明显更高 (RR 2.17,p=0.04).
- 在死亡率,中风,AKI,血管并发症或膜漏洞方面没有显著差异.
结论:
- 在BAV患者中,TAVR提供了相比SAVR的30天出血风险降低.
- TAVR与永久心脏起器植入的风险增加有关.
- 需要进一步的大规模随机试验来评估长期结果.
更多相关视频
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.6K
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
2.8K
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4
